Madurai News

DelveInsight Business Research LLP

DelveInsight has launched a new report on “Thyroid eye disease (TED) -Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Thyroid eye disease (TED)  – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Thyroid eye disease (TED), historical and forecasted epidemiology as well as the  Thyroid eye disease (TED)  market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

1. In a study, it was observed that approximately 25-30% of patients with Graves’ disease have clinical evidence of Graves’ ophthalmopathy.

2. As per the study, TED has a higher prevalence in women than men (16 per 100,000 vs. 3 per 100,000, respectively). Both men and women demonstrate a bimodal pattern of the age of diagnosis (40–44 and 60–64 years in women; 45–49 and 65–69 years in men).

3. The study estimates that Graves’ ophthalmopathy (GO) occurs mainly, but not exclusively, in patients with Graves’ disease. However, only about <50% of Graves’ patients have clinically apparent ophthalmopathy, where the approximate prevalence is 0.25%.

4. According to a review, article ophthalmopathy is clinically relevant in approximately 50% of patients with Graves’ disease, and severe forms affect less than 5% of patients.

Key benefits of the report:

1.The Thyroid eye disease (TED) market report covers a descriptive overview and comprehensive insight of the Thyroid eye disease (TED)  epidemiology and Thyroid eye disease (TED) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2.The Thyroid eye disease (TED) market report provides insights on the current and emerging therapies.

3.Thyroid eye disease (TED) market report provides a global historical and forecasted market covering drug outreach in 7MM.

4.The Thyroid eye disease (TED) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Thyroid eye disease (TED) market.

Request for sample pages: https://www.delveinsight.com/sample-request/thyroid-eye-disease-ted-market

Thyroid eye disease (TED): Overview

TED is an autoimmune disease in which the eye muscles and fatty tissue behind the eye become inflamed. This inflammation can push the eyes forward (“staring” or “bulging”) or cause the eyes and eyelids to become red and swollen. In some individuals, the inflammation may involve the eye muscles, causing the eyes to become out of line, leading to double vision. In rare cases, TED can cause blindness from pressure on the nerve in the back of the eye or ulcers that form on the front of the eye (cornea).

The key players involved in the Thyroid eye disease (TED) market:

1. Immunovant Sciences

2. Horizon Therapeutics

The launch of the emerging therapies is expected to significantly impact the  Thyroid eye disease (TED)  treatment scenario in the upcoming years:-

Drug covered

1. IMVT-1401

2. Teprotumumab

Request a free sample report @https://www.delveinsight.com/sample-request/thyroid-eye-disease-ted-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Thyroid eye disease (TED) Patient Share (%) Overview at a Glance

5. Thyroid eye disease (TED) Market Overview at a Glance

6. Thyroid eye disease (TED) Disease Background and Overview

7. Thyroid eye disease (TED) Epidemiology and Patient Population

8. Country-Specific Patient Population of Thyroid eye disease (TED) 

9. Thyroid eye disease (TED) Current Treatment and Medical Practices

10. Unmet Needs

11. Thyroid eye disease (TED) Emerging Therapies

12. Thyroid eye disease (TED) Market Outlook

13. Country-Wise Thyroid eye disease (TED) Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Thyroid eye disease (TED) Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Thyroid eye disease (TED) -Epidemiology Forecast to 2030

DelveInsight’s ‘Thyroid eye disease (TED) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Thyroid eye disease (TED){;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/